The FDA has granted orphan drug designation (ODD) to a locally delivered formulation of irinotecan (ChemoSeed) for the ...

Despite decades of advancements in surgical techniques, chemotherapy, and radiotherapy, the clinical outlook for patients diagnosed with primary brain tumors remains sobering. Whi ...

Telix has resubmitted the NDA with the additional data requested by the FDA. The Company believes, based on the Type A meeting and ongoing consultation with the FDA, that the additional data and ...

A single genetic abnormality found in more than two-thirds of supratentorial ependymomas, a deadly class of pediatric brain tumors, does far more than activate one inflammatory pathway. The ZFTA-RELA ...

Fred Hutch Cancer Center’s Rare Cancer Patient and Caregivers’ Symposium held March 14 and sponsored by TRACER, Fred Hutch's ...

High-grade gliomas, especially glioblastoma (GBM) and others, remain among the most aggressive brain cancers, with few ...

Jasmin’s cancer is the same as the one suffered by Married at First Sight (MAFS) legend, Mel Schilling, whose death was ...

COPENHAGEN, DENMARK / ACCESS Newswire / March 18, 2026 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company"), a biotech ...

A laboratory abnormality during the evaluation of erectile dysfunction in a young man leads clinicians to identify ...

COPENHAGEN, DENMARK / ACCESS Newswire / March 18, 2026 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company"), a biotech company maximizing surgical outcomes in oncology by lighting up cancer, anno ...

At a General Meeting on 11 June 2025, shareholders approved the subdivision and redesignation of the Company’s Issued ...

Monteris' strong operational results, combined with its near-term pathway to profitability and positive cash flow, allowed the company to retire its prior credit facility with Madryn Asset Management ...